Mortality prediction of septic patients by blood caspase-8 levels.


Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 02 11 2021
revised: 07 01 2022
accepted: 16 01 2022
pubmed: 19 2 2022
medline: 23 3 2022
entrez: 18 2 2022
Statut: ppublish

Résumé

We have not found data about blood caspase-8 concentrations (initiator caspase in the extrinsic pathway of apoptosis) during follow-up of sepsis and this was the objective of our study. We included septic patients. Serum caspase-8 concentrations were determined at days 1, 4, and 8 of sepsis diagnosis. We registered mortality at 30 days. Nonsurviving patients (n = 89) in respect to surviving patients (n = 160) showed higher serum caspase-8 levels at days 1 (P < 0.001), 4 (P <0.001), and 8 (P <0.001) of sepsis diagnosis. Serum caspase-8 levels on day 1, day 4, and day 8 had an area under curve for the prediction of 30-day mortality of 68% (60%-75%, P<0.001), 72% (62%-82%, P<0.001), and 81% (73%-90%, P<0.001). Thus, that blood caspase-8 concentrations at any time during the first week of sepsis were higher in non-survivor than in survivor patients and that were able to predict mortality were new findings in our study.

Identifiants

pubmed: 35180643
pii: S0732-8893(22)00007-4
doi: 10.1016/j.diagmicrobio.2022.115639
pii:
doi:

Substances chimiques

CASP8 protein, human EC 3.4.22.-
Caspase 8 EC 3.4.22.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115639

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Leonardo Lorente (L)

Intensive Care Unit, Hospital Universitario de Canarias, Ofra, s/n, La Laguna, 38320, Tenerife, Spain. Electronic address: lorentemartin@msn.com.

María M Martín (MM)

Intensive Care Unit, Hospital Universitario Nuestra Señora Candelaria, Crta Rosario s/n, Santa Cruz Tenerife, 38010, Spain.

Raquel Ortiz-López (R)

Intensive Care Unit, Hospital General de La Palma, Buenavista de Arriba s/n, Breña Alta, La Palma, 38713, Spain.

Agustín F González-Rivero (AF)

Laboratory Department, Hospital Universitario de Canarias, Ofra, s/n, La Laguna, 38320, Santa Cruz de Tenerife, Spain.

Jacobo J Villacampa-Jiménez (JJ)

Laboratory Department, Hospital Universitario de Canarias, Ofra, s/n, La Laguna, 38320, Santa Cruz de Tenerife, Spain.

Alejandro Jiménez (A)

Research Unit, Hospital Universitario de Canarias, Ofra, s/n, La Laguna, 38320, Tenerife, Spain.

Antonia Pérez-Cejas (A)

Laboratory Department, Hospital Universitario de Canarias, Ofra, s/n, La Laguna, 38320, Santa Cruz de Tenerife, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH